376 related articles for article (PubMed ID: 22553111)
21. The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses.
Vigant F; Hollmann A; Lee J; Santos NC; Jung ME; Lee B
J Virol; 2014 Feb; 88(3):1849-53. PubMed ID: 24284320
[TBL] [Abstract][Full Text] [Related]
22. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
23. Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle.
Owen L; Laird K; Shivkumar M
Lett Appl Microbiol; 2022 Sep; 75(3):476-499. PubMed ID: 34953146
[TBL] [Abstract][Full Text] [Related]
24. Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses.
De Clercq E; Field HJ
Antivir Chem Chemother; 2008; 19(2):63-74. PubMed ID: 18727441
[TBL] [Abstract][Full Text] [Related]
25. Structure Properties and Mechanisms of Action of Naturally Originated Phenolic Acids and Their Derivatives against Human Viral Infections.
Wu YH; Zhang BY; Qiu LP; Guan RF; Ye ZH; Yu XP
Curr Med Chem; 2017; 24(38):4279-4302. PubMed ID: 28814240
[TBL] [Abstract][Full Text] [Related]
26. Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.
De Clercq E
Adv Virus Res; 1993; 42():1-55. PubMed ID: 8430518
[TBL] [Abstract][Full Text] [Related]
27. The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.
De Clercq E
Med Res Rev; 2011 Jan; 31(1):118-60. PubMed ID: 19844936
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
29. Curious (Old and New) Antiviral Nucleoside Analogues with Intriguing Therapeutic Potential.
De Clercq E
Curr Med Chem; 2015; 22(34):3866-80. PubMed ID: 26112146
[TBL] [Abstract][Full Text] [Related]
30. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease.
Hussein ITM; Brooks J; Bowlin TL
Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473
[TBL] [Abstract][Full Text] [Related]
31. The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo.
Dong HJ; Wang ZH; Meng W; Li CC; Hu YX; Zhou L; Wang XJ
Viruses; 2018 Nov; 10(11):. PubMed ID: 30388805
[TBL] [Abstract][Full Text] [Related]
32. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
33. Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.
De Clercq E
Med Res Rev; 2009 Jul; 29(4):611-45. PubMed ID: 19260077
[TBL] [Abstract][Full Text] [Related]
34. Yet another ten stories on antiviral drug discovery (part D): paradigms, paradoxes, and paraductions.
De Clercq E
Med Res Rev; 2010 Jul; 30(4):667-707. PubMed ID: 19626594
[TBL] [Abstract][Full Text] [Related]
35. In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.
Chemaly RF; Hill JA; Voigt S; Peggs KS
Antiviral Res; 2019 Mar; 163():50-58. PubMed ID: 30677427
[TBL] [Abstract][Full Text] [Related]
36. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
Kumar R
Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474
[TBL] [Abstract][Full Text] [Related]
37. Broad-spectrum antivirals against viral fusion.
Vigant F; Santos NC; Lee B
Nat Rev Microbiol; 2015 Jul; 13(7):426-37. PubMed ID: 26075364
[TBL] [Abstract][Full Text] [Related]
38. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
[TBL] [Abstract][Full Text] [Related]
39. Antiphage activity of natural and synthetic substances: a new age for antivirals?
Ribeiro JM; Pereira GN; Kobayashi RK; Nakazato G
Future Microbiol; 2020 Jun; 15():767-777. PubMed ID: 32700548
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of an aqueous extract from Cortex Phellodendri on the growth and replication of broad-spectrum of viruses in vitro and in vivo.
Kim JH; Weeratunga P; Kim MS; Nikapitiya C; Lee BH; Uddin MB; Kim TH; Yoon JE; Park C; Ma JY; Kim H; Lee JS
BMC Complement Altern Med; 2016 Aug; 16():265. PubMed ID: 27484768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
